Dhar; Shanta
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dhar; Shanta.The latest application filed is for "nanoparticles for mitochondrial trafficking of agents".
- Dhar; Shanta - Miami FL
- Dhar; Shanta - Athens GA
- Dhar; Shanta - Cambridge MA
| Patent | Date |
|---|---|
| Nanoparticles for mitochondrial trafficking of agents Grant 10,845,368 - Dhar , et al. November 24, 2 | 2020-11-24 |
| Nanoparticles For Mitochondrial Trafficking Of Agents App 20200003782 - Dhar; Shanta ; et al. | 2020-01-02 |
| Platinum prodrugs and methods of making and using thereof Grant 10,457,700 - Dhar , et al. Oc | 2019-10-29 |
| Nanoparticles for mitochondrial trafficking of agents Grant 10,416,167 - Dhar , et al. Sept | 2019-09-17 |
| Mitochondrial delivery of 3-bromopyruvate Grant 10,398,663 - Dhar , et al. Sep | 2019-09-03 |
| Precise delivery of therapeutic agents to cell mitochondria for anti-cancer therapy Grant 10,004,809 - Dhar , et al. June 26, 2 | 2018-06-26 |
| Mitochondria-targeting Platinum(iv) Prodrug App 20180066004 - Dhar; Shanta ; et al. | 2018-03-08 |
| Apoptosis-targeting nanoparticles Grant 9,901,616 - Dhar , et al. February 27, 2 | 2018-02-27 |
| Platinum Prodrugs And Methods Of Making And Using Thereof App 20180044362 - Dhar; Shanta ; et al. | 2018-02-15 |
| Nanoparticles For Lipid Homeostasis App 20170367989 - Dhar; Shanta ; et al. | 2017-12-28 |
| Therapeutic Nanoparticles For Accumulation In The Brain App 20170216219 - Dhar; Shanta ; et al. | 2017-08-03 |
| Prodrug For Release Of Cisplatin And Cyclooxygenase Inhibitor App 20170190726 - Dhar; Shanta ; et al. | 2017-07-06 |
| Platinum(iv) Compounds And Methods Of Making And Using Same App 20170096443 - Dhar; Shanta ; et al. | 2017-04-06 |
| Modification Of Drugs For Incorporation Into Nanoparticles App 20170087167 - Kalathil; Akil Abraham ; et al. | 2017-03-30 |
| Mitochondria-targeting Platinum(iv) Prodrug App 20170037071 - Dhar; Shanta ; et al. | 2017-02-09 |
| Mitochondrial Delivery Of 3-bromopyruvate App 20170014361 - Dhar; Shanta ; et al. | 2017-01-19 |
| Combination Therapeutic Nanoparticles App 20170000740 - Dhar; Shanta ; et al. | 2017-01-05 |
| Immune-stimulating photoactive hybrid nanoparticles Grant 9,517,277 - Dhar , et al. December 13, 2 | 2016-12-13 |
| Prodrug For Release Of Cisplatin And Cyclooxygenase Inhibitor App 20160326200 - Dhar; Shanta ; et al. | 2016-11-10 |
| Platinum (IV) complexes for use in dual mode pharmaceutical therapy Grant 9,265,747 - Lippard , et al. February 23, 2 | 2016-02-23 |
| Combination Therapeutic Nanoparticles App 20160045445 - Dhar; Shanta ; et al. | 2016-02-18 |
| Nanoparticles For Mitochondrial Trafficking Of Agents App 20160022825 - Dhar; Shanta ; et al. | 2016-01-28 |
| Generation Of Functional Dendritic Cells App 20150374714 - Dhar; Shanta ; et al. | 2015-12-31 |
| Nanostructures for drug delivery Grant 8,906,417 - Lippard , et al. December 9, 2 | 2014-12-09 |
| Apoptosis-targeting Nanoparticles App 20140303081 - Dhar; Shanta ; et al. | 2014-10-09 |
| Immune-stimulating Photoactive Hybrid Nanoparticles App 20140220143 - Dhar; Shanta ; et al. | 2014-08-07 |
| Nanostructures for Drug Delivery App 20140079776 - Lippard; Stephen J. ; et al. | 2014-03-20 |
| Nanostructures for drug delivery Grant 8,603,532 - Lippard , et al. December 10, 2 | 2013-12-10 |
| Particles For Multiple Agent Delivery App 20130017265 - Farokhzad; Omid C. ; et al. | 2013-01-17 |
| Polyvalent Polynucleotide Nanoparticle Conjugates As Delivery Vehicles For A Chemotherapeutic Agent App 20120244230 - Mirkin; Chad A. ; et al. | 2012-09-27 |
| Nanostructures For Drug Delivery App 20110300219 - Lippard; Stephen J. ; et al. | 2011-12-08 |
| Platinum (iv) Complexes For Use In Dual Mode Pharmaceutical Therapy App 20110257261 - Lippard; Stephen J. ; et al. | 2011-10-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 